{"schema_version":"secwatch.filing_event.v1","accession":"0001356576-24-000022","form_type":"8-K","ticker":"SUPN","cik":"0001356576","company_name":"SUPERNUS PHARMACEUTICALS, INC.","filed_at":"2024-04-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.072550+00:00","generated_at":"2026-06-03T09:26:12.219442+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.05,"calibrated_materiality_score":0.05,"confidence":"high","headline":"Supernus to report Q1 2024 results after market close on May 8, 2024","bullets":["Q1 2024 financial and business results will be released after market close on Wednesday, May 8, 2024.","Conference call and webcast scheduled for 4:30 p.m. ET on May 8, 2024, hosted by CEO Jack Khattar and CFO Tim Dec.","No preliminary financial data or guidance was provided in the announcement."],"urls":{"canonical":"https://secwatch.observer/filing/0001356576-24-000022","json":"https://secwatch.observer/filing/0001356576-24-000022.json","markdown":"https://secwatch.observer/filing/0001356576-24-000022.md","text":"https://secwatch.observer/filing/0001356576-24-000022.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000022/0001356576-24-000022-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1356576/000135657624000022/supn-20240424.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-03T09:26:12.219442+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}